Browsing by Yonsei Author : Kim, Jin Seok

Name:
Kim, Jin Seok [김진석] http://orcid.org/0000-0001-8986-8436
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Y-HRN :
(Yonsei Health Research Network)
Scopus ID :
(55032033600)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleJournal Title
2012Clinical features and outcomes of Hodgkin’s lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)ANNALS OF HEMATOLOGY
2012Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) studyANNALS OF HEMATOLOGY
2012Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trialEUROPEAN JOURNAL OF CANCER
2012다발성 골수종 환자에서 발생한 Arthrobacter woluwensis 균혈증 1예 보고 및 문헌 고찰 INFECTION AND CHEMOTHERAPY
2012Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL). JOURNAL OF HEMATOLOGY & ONCOLOGY
2012Non-bacterial infections in Asian patients treated with alemtuzumab:a retrospective study of the Asian Lymphoma Study GroupLEUKEMIA & LYMPHOMA
2012Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis.ANNALS OF ONCOLOGY
2012Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphomaAMERICAN JOURNAL OF HEMATOLOGY
2012Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: Results of a phase II trialANNALS OF HEMATOLOGY
2012Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairmentANNALS OF HEMATOLOGY
2012Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factorsANNALS OF HEMATOLOGY
2012Risk Factors for Progression from Cytomegalovirus Viremia to Cytomegalovirus Disease after Allogeneic Hematopoietic Stem Cell TransplantationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2012Waldeyer's ring marginal zone B cell lymphoma: Are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL)INTERNATIONAL JOURNAL OF HEMATOLOGY
201218F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography in symmetrically enlarged axillary and inguinal lymph nodes of Ofuji's papuloerythrodermaLEUKEMIA & LYMPHOMA
2012Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphomaLEUKEMIA & LYMPHOMA
2012Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients.MEDICAL ONCOLOGY
2012Myeloperoxidase expression in acute myeloid leukemia helps identifying patients to benefit from transplant YONSEI MEDICAL JOURNAL
2012Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapyINTERNATIONAL JOURNAL OF CANCER
2011Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trialINVESTIGATIONAL NEW DRUGS
2011Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemmaANNALS OF HEMATOLOGY
2011Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience.INTERNATIONAL JOURNAL OF HEMATOLOGY
2011Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Korean Journal of Hematology
2011Acute promyelocytic leukemia with trisomy 8 and del(9)(q22) after treatment of cervical cancer with concurrent chemoradiotherapy: a case report.ONKOLOGIE
2011Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation.ANNALS OF HEMATOLOGY
2011Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy. JOURNAL OF HEMATOLOGY & ONCOLOGY
2011Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC CANCER
2011Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. BLOOD
2010Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study BMC CANCER
2010Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia.CANCER GENETICS AND CYTOGENETICS
2010Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study.INTERNATIONAL JOURNAL OF HEMATOLOGY
2010Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party.INTERNATIONAL JOURNAL OF HEMATOLOGY
2010Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
2010Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) studyCANCER SCIENCE
2010The use of the complement inhibitor eculizumab (Soliris(R)) for treating Korean patients with paroxysmal nocturnal hemoglobinuria Korean Journal of Hematology
2010Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis.CELL TRANSPLANTATION
2010Inhibition of CK2{alpha} and PI3K/Akt synergistically induces apoptosis of CD34+CD38- leukaemia cells while sparing haematopoietic stem cells.ANTICANCER RESEARCH
2010Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) studyANNALS OF HEMATOLOGY
2010Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report.LEUKEMIA RESEARCH
2010Active locomotion of a paddling-based capsule endoscope in an in vitro and in vivo experiment (with videos).GASTROINTESTINAL ENDOSCOPY
2010베체트 장염에서 발생한 8번과 9번 삼염색체를 동반한 재생불량성 빈혈 Korean Journal of Gastroenterology (대한소화기학회지)
2010Nonspecific interstitial pneumonitis after bortezomib and thalidomide treatment in a multiple myeloma patient YONSEI MEDICAL JOURNAL
2010A novel t(1;12)(q21;q24) in a patient with myelodysplastic syndromeANNALS OF HEMATOLOGY
2009Acute promyelocytic leukemia with insertion of PML exon 7a and partial deletion of exon 3 of RARA: a novel variant transcript related to aggressive course and not detected with real-time polymerase chain reaction analysisCANCER GENETICS AND CYTOGENETICS
2009Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study JOURNAL OF CLINICAL ONCOLOGY
2009Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2009Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcriptsCANCER GENETICS AND CYTOGENETICS
2009Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcomeBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2009Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma RegistryACTA HAEMATOLOGICA
2009A successful treatment of relapsed primary CNS lymphoma patient with intraventricular rituximab followed by high-dose chemotherapy with autologous stem cell rescue. YONSEI MEDICAL JOURNAL
2009Chronic myelomonocytic leukemia with der(9)t(1;9)(q11;q34) as a sole abnormalityANNALS OF CLINICAL AND LABORATORY SCIENCE

Browse

Links